Patents
Patents for C07C 281 - Derivatives of carbonic acid containing functional groups covered by groups in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group (2,117)
04/2007
04/24/2007US7208299 Controlling adhesion of cells to hydrophobic surfaces using biomolecule conjugated end group activated polymer
04/18/2007EP1446378B1 Method and apparatus for preparing hydrazo-dicarbonamide using urea as starting material
04/18/2007CN1310905C Antivirally active heterocyclic azahexane derivatives
04/11/2007EP1601642A4 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/2007
03/22/2007US20070066617 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly
03/21/2007CN1934076A Method for producing semicarbazones
03/15/2007US20070059299 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection
03/07/2007EP1758569A2 Guanylhydrazone salts, compositions, processes of making and methods of using
02/2007
02/28/2007CN1301974C Muller Klaus-helmut
02/20/2007US7179913 Process for preparing a pharmaceutically active compound and for preparing its intermediate
02/14/2007EP1751553A2 Identification of anti-prion drugs by high-throughput screening based on sift
02/13/2007CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
02/13/2007CA2112420C N-arylhydrazine derivatives as insecticidal and acaricidal agents
02/08/2007WO2007015999A2 Process for synthesizing a substituted pyrazole
02/08/2007CA2614537A1 Process for synthesizing a substituted pyrazole
01/2007
01/23/2007US7166593 Glucocorticoid receptor modulators
01/17/2007EP1742907A2 Certain chemical entities, compositions, and methods
01/17/2007CN1295210C Biurea synthesis technology
01/04/2007WO2007000250A1 Method for producing aryl amines, aryl ethers and aryl thioethers
01/03/2007EP1539720B8 New process for the synthesis of high purity 3,5-diamino-6-(2, 3-dichlorophenyl)-1,2,4-triazine
01/03/2007EP1334661B1 Ectoparasitic insect pest controllers for animals and their usage
12/2006
12/28/2006DE102005030400A1 Verfahren zur Herstellung von Arylaminen, Arylethern und Arylthioethern Process for the preparation of aryl amines, aryl ethers and aryl thioethers
12/26/2006US7153881 Compounds acting as melanocortin receptor ligands
12/14/2006US20060281686 Aza-peptides
12/13/2006EP1731512A1 Isoxazoline-substituted benzamide compound and noxious organism control agent
12/13/2006CN1878752A Cis-trans isomerisation of semicarbazone compounds
12/06/2006EP1727792A1 Method for producing semicarbazones
11/2006
11/23/2006US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/22/2006EP1539720B1 New process for the synthesis of high purity 3,5-diamino-6-(2, 3-dichlorophenyl)-1,2,4-triazine
11/21/2006CA2163519C Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
11/02/2006US20060247289 Certain chemical entities, compositions, and methods
11/02/2006EP1419126B1 Fluorous nucleophilic substitution of alcohols and reagents for use therein
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/25/2006EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006EP1713822A2 Hcv ns-3 serine protease inhibitors
10/18/2006CN1279822C Synergistic insecticidal compositions
10/04/2006EP0906091B1 Amidinohydrazones as protease inhibitors
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
09/2006
09/20/2006CN1275917C Glucocorticoid receptor modulators
09/08/2006WO2006093124A1 Free radical scavenger containing semicarbazide derivative
09/05/2006US7101915 P-terphenyl compounds
09/05/2006US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration
08/2006
08/31/2006WO2006048526A3 Non-irritating rapid-action depilatory composition
08/23/2006EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same
08/17/2006WO2005107762A3 Certain chemical entities, compositions, and methods
08/10/2006WO2006083266A1 Inhibitors of bacterial type iii protein secretion systems
08/10/2006US20060178511 2,3-dichlorobenzoyl cyanide is reacted with 1-2 mol equivalent of aminoguanidine salt in 3-6 mol equivalent of methanesulfonic acid, then the obtained adduct is transformed without isolation into the product with magnesium oxide
08/09/2006EP1687641A2 Treating neuropathic pain with neuropeptide ff receptor 2 agonists
08/09/2006EP1687263A1 Cis-trans isomerisation of semicarbazone compounds
08/03/2006WO2006032893A3 Trityl derivatives for enhancing mass spectrometry
08/02/2006EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines
08/02/2006CN1812779A Compounds for treatment of inflammation, diabetes and related disorders
08/01/2006CA2379334C Aminoguanidine bicarbonate with particular properties and method for making same
08/01/2006CA2188400C Preparation of arthropodicidal oxadiazines
07/2006
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2006CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof
07/19/2006CN1264809C Method for preparing hydrazodicarbonamide using biuret as starting material
07/18/2006US7078566 Organic acid salts for treating tumor diseases, autoimmune diseases, cardiovascular diseases, infections, and viral diseases; nonsettling by inorganic phosphates, nontoxic to tissue, inhibition of sphingomyelinase
07/12/2006CN1799358A Synergistic insecticidal compositions
07/11/2006US7074836 Para-terphenyl compounds
07/04/2006US7071211 Vision disorders; adjustment activation of gelatinase
07/04/2006CA2250840C Antivirally active heterocyclic azahexane derivatives
06/2006
06/08/2006US20060121090 Ocular compositions that increases the activity of gelatinase a in ocular cells
06/07/2006CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
05/2006
05/30/2006CA2158713C Process for the preparation of alkoxytriazolinones
05/30/2006CA2158712C Process for the preparation of alkoxytriazolinones
05/24/2006EP1250310B1 Method for synthesizing hydrazodicarbonamide
05/11/2006WO2006048526A2 Non-irritating rapid-action depilatory composition
05/11/2006CA2584791A1 Non-irritating rapid-action depilatory composition
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/02/2006CA2250426C Amidinohydrazones as protease inhibitors
04/2006
04/26/2006CN1762989A Semicarbazone synthesis method
04/05/2006EP1641747A2 Acicular crystals of hydrazine-based diurea derivatives and their use as rheology modifiers in coating and adhesive compositions
04/05/2006EP0933993B1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
03/2006
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/28/2006US7019003 Bactericides
03/22/2006CN1246293C Method and apparatus for preparing hydrazo-dicarbonamide using urea as starting material
03/21/2006CA2158691C Process for the preparation of alkoxytriazolinones
03/15/2006EP1633702A1 Protease inhibitors
03/09/2006WO2005116640A3 Identification of anti-prion drugs by high-throughput screening based on sift
03/09/2006US20060052625 Reaction of 2,3-dichlorobenzoyl cyanide with aminoguanidine bicarbonate in non-aqueous medium in the presence of methanesulphonic acid to form intermediate 2-(2,3-dichlorophenyl)-2-(aminoguanidine)acetonitrile, cyclizing the intermediate to form 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
03/09/2006US20060052355 reacting a chloro contaiing triaryl- or trialkyl-orthoester with a sulfonic acid salt of semicarbazide in an organic solvent, adding a brine solution to the concentrated reaction mixture,cooling the mixture to form a solid product, acidification with aqueous acid
03/08/2006EP1631586A2 Peptide analogues comprising at least one type of aminoacyl aza-beta 3 and the use thereof, in particular for therapy
02/2006
02/21/2006US7001924 Inhibitors of RNase P proteins as antibacterial compounds
02/16/2006WO2004101752A3 Compounds for treatment of inflammation, diabetes and related disorders
02/15/2006EP1625207A2 Compounds for treatment of inflammation, diabetes and related disorders
02/15/2006CN1733711A Biurea synthesis technology
02/08/2006EP1623980A1 Preparation of arthropodicidal oxadiazines
02/01/2006CN1729172A Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
01/2006
01/26/2006US20060020146 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
01/04/2006EP1363873A4 Peptide deformylase inhibitors
12/2005
12/27/2005US6979567 Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
12/14/2005EP1224165B1 Novel compounds
12/14/2005EP1198170B1 Synergistic insecticidal compositions
12/07/2005EP1601642A2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/2005
11/29/2005CA2080545C Salts of hydrazones
11/24/2005US20050258553 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms
11/23/2005EP1598332A2 Indanones and carbamates, and their use in the preparation of anthropodicidal oxadiazines
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 22